Advisory Committee on Immunization Practices

View All		Childhood		HIV		Registries
Adolescents		Combination Vaccines		Long-Term Care		Schedules
Adoption		Dialysis		Men + Men		Travel
Adults		Healthcare Personnel		Postexposure Prophylaxis
Biopreparedness		HepB Birth Dose		Pregnancy

Recommendations - Childhood

Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Source: MMWR, March 22, 2013; 62(RR02):1-22 HTML  |  PDF Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale Source: MMWR, January 25, 2013; 62(3):52-4 HTML  |  PDF Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season Source: MMWR, August 18, 2012;61(32);613-8 HTML  |  PDF Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012 Source: MMWR, February 10, 2012; 61(5):1-4 HTML  |  PDF   Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease Source: MMWR, October 14, 2011; 60(40):1391-2 HTML  |  PDF   Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011 Source: MMWR, August 5, 2011; 60(30):1018-1019 HTML  |  PDF   General Recommendations on Immunization Source: MMWR, January 28, 2011; 60(RR02):1-60 HTML  |  PDF

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010 Source: MMWR, January 14, 2011; 60(01):13-15 HTML  |  PDF

Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Source: MMWR, December 10, 2010; 59(RR11):1-18

HTML  |  PDF

Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11 Source: MMWR, August 13, 2010; 59(31):989-92

HTML  |  PDF

Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices Source: MMWR, May 7, 2010; 59(RR--3):1 - 16

HTML  |  PDF

Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010 Source: MMWR, March 12, 2010; 59(09):258-261

HTML  |  PDF

Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine Source: MMWR September 18, 2009; 58(36):1008-1009

HTML  |  PDF

Use of Influenza A (H1N1) 2009 Monovalent Vaccine Source: MMWR, August 28, 2009; 58(RR10):1-8

HTML  |  PDF

Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination Source: MMWR, August 7, 2009; 58(30):829-30

HTML  |  PDF

Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices Source: MMWR, February 6, 2009, Vol. 58 (RR-2)

HTML  |  PDF

Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated Source: MMWR, April 4, 2008; 57(13):343-344

HTML  |  PDF

Notice to Readers: Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease Source: MMWR, December 7, 2007; 56(48):1265-1266

HTML  |  PDF

Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season Source: MMWR, November 23, 2007; 56(46):1217-1219

HTML  |  PDF

Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine Source: MMWR, August 10, 2007; 56(31):794-795

HTML  |  PDF

Prevention of Varicella Source: MMWR, June 22, 2007; 56(RR-4):1-40

HTML  |  PDF

Quadrivalent Human Papillomavirus Vaccine Source: MMWR, March 23, 2007; 56(RR02):1-24

HTML  |  PDF

Control and Elimination of Mumps Source: MMWR, June 9, 2006, Vol. 55(22):629-630

HTML  |  PDF

Prevention and Control of Meningococcal Disease Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21

HTML  |  PDF

Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)

HTML  |  PDF

Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13

HTML  |  PDF

Preventing Pneumococcal Disease Among Infants and Young Children Source: MMWR October 6, 2000 / Vol. 49 / No. RR-09

HTML  |  PDF

Prevention and Control of Meningococcal Disease Source:MMWR June 30, 2000 / Vol. 49 / No. RR-07

HTML  |  PDF

Poliomyelitis Prevention in the United States Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05

HTML  |  PDF

Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13

HTML  |  PDF

Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10

HTML  |  PDF

Haemophilus b Conjugate Vaccines for Prevention of Hib Disease Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01

HTML  |  PDF

This page was reviewed on March 22, 2013